# A Long-term Trial of OPC-34712 in Patients With Schizophrenia

> **NCT01456897** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 282 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** OPC-34712

## Key facts

- **NCT ID:** NCT01456897
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2015-05
- **Final completion:** —
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2019-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01456897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01456897, "A Long-term Trial of OPC-34712 in Patients With Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01456897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*